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Abstract Some health problems are considered by many
individuals as a ‘normal’ part of ageing. Our aim was to
investigate whether patients with rheumatoid arthritis (RA)
consider different types and levels of health losses as
acceptable beyond a certain age. A multicenter cross-sec-
tional survey was performed involving RA patients at the
initiation of the first biological therapy. The EQ-5D and the
Health Assessment Questionnaire Disability Index (HAQ-
DI) questionnaires were used to describe domain-specific
health states. Patients were asked to indicate for each
domain from what age and onward (between ages 30 and
80 years in 10 year intervals) they considered moderate
and severe problems acceptable or alternatively never
acceptable. Seventy-seven RA patients (females 86 %,
mean age 50.3, disease duration 9.1 years) completed the
questionnaire. Disease activity (DAS28), EQ-5D and
HAQ-DI scores were mean 6.00 (SD 0.85), 0.35 (SD 0.36),
1.48 (SD 0.66), respectively. The majority of the patients
considered age 70 and beyond as acceptable to have some
health problems (EQ-5D: self-care 42 %, pain/discomfort
34 %, mobility 33 %, usual activities 33 %, anxiety/
depression 27 %), whilst at ages 30 and 40 as not
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acceptable. Severe health problems were mostly (57–69 %)
considered never acceptable, except the ‘Usual activities’
domain (acceptable from age 80 by 50.6 %). The great
majority of the patients (77–96 %) were younger than what
they indicated as the acceptability age limit. Similar results
were found for the HAQ-DI. This small experimental study
suggests that RA patients consider some health problems
acceptable. This acceptability is age related and varies by
health areas. Further larger studies are needed to explore
explanatory variables and to compare with other diseases.
Owing to the impact acceptability might have on RA
patients’ self-evaluation of current health state and deci-
sion-making, the topic deserves methodological improve-
ment and further investigation.
Keywords Health status  Rheumatoid arthritis 
Acceptability  EQ-5D  HAQ-DI
JEL Classification I19
Introduction
Albeit health, by definition (WHO, 1948) is ‘a state of
complete physical, mental and social well-being and not
merely the absence of disease or infirmity’ [1], individuals
commonly consider the gradual appearance of some health
declines as a natural part of healthy ageing. For instance,
slowing in mobility in advanced stages of life is usually
acceptable for most people or similarly, when the eyes can
no longer focus enough to see close objects clearly above a
certain age. There is no universal definition of normal
healthy ageing [2]. Academic researchers and lay older
people certainly have diverse views, and there are cross-
cultural differences as well [3]. Traditions, people’s pre-
vious experiences and subjective expectations regarding
health might also shape what types and levels of disabilities
are considered as a normal part of health in the elderly.
Moreover, with the development of new medical technol-
ogies some health states or symptoms that formerly were
considered as ‘normal’ when people age are now viewed as
potentially treatable diseases. Loss of teeth, for instance, is
no more an unavoidable part of normal ageing with the
advances in and availability of professional dental care.
Occasional lapses in memory are observed as potential first
signs of Alzheimer disease. Joint deformities in the elderly
are viewed as probable symptoms of late onset rheumatoid
arthritis (RA), an autoimmune disorder with a wide
armamentarium of effective therapies. Thus, healthy age-
ing is a multidimensional, complex and inevitably chang-
ing concept and people’s attitudes towards health during
the life course are influenced by a broad spectrum of fac-
tors. Nevertheless, taking in consideration the impact
people’s beliefs on normal healthy ageing might have on
their health behaviour (e.g., evaluating health gains, seek-
ing for medical care, following medical advice) the topic
deserves attention [4].
Brouwer et al. [5] investigated the acceptability of
health deterioration in a web-based population survey in
the Netherlands. They used statements of a generic health
status measure, the EQ-5D [6] to assess the acceptability of
health decline with age. As compared to previous studies,
this research contributed significantly to the literature in
providing comparable results with population health state
norms. Results revealed that often individuals do indeed
consider less than perfect health states acceptable, espe-
cially at older ages. Authors highlight that the erosion of
health capabilities over time is evident for the society, and
this seems to have shifted the society’s reference point for
health in advanced stages of life to points below perfect
health. Nevertheless, the acceptability is strongly related to
the severity of the health state, and the worst states are
considered as never acceptable.
In this study we aimed to test these observations from
the perspective of patients with a chronic progressive dis-
ease, namely RA. This inflammatory condition often starts
in middle age and is most common in older people. Hence,
perception of health changes as age-related phenomena or
rather disease-related symptoms is a relevant issue for RA
patients. Furthermore, people with RA, particularly whose
disease is not (or cannot be) well controlled, have to face a
progressive disability over time and adapt to at least some
health problems. Moreover, a shared decision making
between the patient and clinician is an explicit requirement
in RA care. The ‘treat-to-target’ approach has been intro-
duced in RA care, which aims to attain remission or low
disease activity by strict (every 1–3 months) monitoring of
patients and therapy adjustments [7]. Setting up the treat-
ment target, however, can be challenging, especially in
long-standing cases and patients’ compliance is crucial for
the successful implementation. Achievement of the best
possible or perfect health state is not necessarily the only
and most important goal for RA patients. Poulos et al. [8]
proved that RA patients would be willing to accept treat-
ments with lower efficacy or greater risks of side effects if
these treatments had lower treatment duration or frequency.
Age was shown to interact significantly with patients’
preferences regarding treatment efficacy levels in a dis-
crete-choice experiment by Augustovski et al. [9], involv-
ing biological drug-naı¨ve RA patients. Younger patients
(B55 years) valued more negatively even small differences
in efficacy (e.g., 40 mm versus 30 or 20 mm mean dif-
ference on the Patient Global Assessment scale before and
after therapy) whilst older patients were more tolerant in
this respect [9]. Moreover, it has been demonstrated that
higher age is associated with more insufficient knowledge
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and lesser information needs in RA [10]. This barrier can
also influence RA patients’ attitudes towards the accep-
tance of less than perfect health states.
Hence, there is apparently a need to gain insight into RA
patients’ preferences in terms of acceptability of health
problems. Age related acceptability of less than perfect
health states, as Brouwer et al. [5] pointed out, may have
implications for the way in which health state valuations
should be elicited and how to value health changes at
different stages in life. Moreover, a better understanding of
patients’ perspectives can improve health professionals’
approach to giving information, such as to discuss what is
achievable, to encourage patients to participate in the
therapy and to formulate realistic expectations. These,
above all, can help physicians in designing a consensus
based therapeutic goal, improving patients’ compliance and
optimizing the use of costly drugs [11, 12].
The objective of this study was, therefore, to assess
whether patients with RA consider certain health problems
acceptable and whether this acceptability is age related and
differs by health areas. We surveyed RA patients at a
significant point of their care, namely at the initiation of
first biological treatment. Besides using the EQ-5D
descriptive system, we included statements of a disease-
specific questionnaire (the Health Assessment Question-
naire Disability Index, HAQ-DI), a simple self-assessment
tool for the evaluation of functional abilities in RA [13].
Methods
Study design and patients
The survey was carried out as a part of a multicentre study
which aimed to assess characteristics of RA patients
starting biological treatment and to explore subjective
health expectations and acceptability of health problems.
Details of the research and primary results have been
published elsewhere [14] and expectations related results
are presented in a companion article in this Supplement
[15]. In brief, a questionnaire survey was performed in
2009 in 12 hospital based rheumatology centres. Adult
patients with RA attending routine care were invited to
participate in the study. Criterion for inclusion was also the
initiation of first biological drug treatment at the time of the
survey. Authorization by the national ethical committee
was obtained (ETT-TUKEB 8-66/2009-1018EKU) and
patients signed informed consent.
Health state assessment: DAS28, EQ-5D, HAQ-DI
Demographic data, clinical history were recorded and
current health state of the patients was evaluated by
validated instruments. Disease activity was assessed by the
Disease Activity Score (DAS28) which considers the
number of tender and swollen joints of 28 specific sites
(evaluated by rheumatologists), one laboratory test on
inflammation (Westergren test or C-reactive protein level)
and patient’s global assessment of disease activity on a
Visual Analogue Scale (VAS). The DAS28 can be used to
determine whether the disease is under control (high, low
activity or remission) and to establish a treatment target
score to aim for [16, 17].
The EQ-5D was applied to measure patients’ general
health state. The questionnaire essentially consists of two
pages. The EQ-5D-3L descriptive system comprises five
health dimensions: mobility, self-care, usual activities,
pain/discomfort and anxiety/depression. Each dimension
has three levels of responses: no problems (1), some/
moderate problems (2), and unable to do/extreme problems
(3). The digits (1, 2 or 3) for five dimensions can be
combined in a 5-digit number describing the respondent’s
health state, which can be converted to a single utility score
(EQ-5D score). A validated Hungarian version of the
questionnaire is available, however, due to lack of national
tariffs the UK utility scores were used in this study. The
second part of the EQ-5D questionnaire is a health ther-
mometer (EQ VAS, range 0–100). Higher EQ-5D and EQ
VAS scores correspond to a better health state [6, 11].
The validated Hungarian version of the HAQ-DI was
used to assess patients’ functional state. The HAQ-DI
comprises 20 questions in eight categories covering a
comprehensive set of functional activities, namely, dress-
ing, rising, eating, walking, hygiene, reach, grip, and usual
activities. Each category contains at least two specific
component questions. The stem of each item asks over the
past week ‘Are you able to …’ perform a particular task.
The patient’s responses are made on a four-level difficulty
scale from zero to three: without any difficulty (0), with
some difficulty (1), with much difficulty (2), and unable to
do (3). The highest component score determines the score
of the category and the eight category scores are averaged
into an overall HAQ-DI score. Higher HAQ-DI score
represents worse functional abilities [13].
Assessment of acceptability of health problems
Statements of the EQ-5D descriptive system and HAQ-DI
were used to assess the level of problems RA patients
consider acceptable beyond certain ages. Patients were
asked to indicate for each EQ-5D-3L statement from which
age between 30 and 80 in 10 year intervals they consider
the two difficulty levels (e.g., mobility: some problems
with walking; confined to bed) as acceptable, or alterna-
tively never acceptable. This method has been successfully
used in the Netherlands in a population survey [5]. The
The patients’ perspective S75
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HAQ-DI statements and problem levels (‘some difficulty’,
‘much difficulty’ or ‘unable to do’) were surveyed
similarly.
Statistics
Questionnaire data were recorded in IBM SPSS, Release
20.0 (IBM, Armonk, NY, USA) software and descriptive
statistics were performed. Furthermore, the average age at
which moderate and severe health problems were consid-
ered acceptable was calculated for those respondents who
did not indicate ‘never’, and results were set against a non-
representative population study from the Netherlands [5].
Findings were also compared to the health state of the
general population in Hungary by age-groups [12].
Results
Patients’ characteristics
Altogether 92 RA patients completed the research ques-
tionnaire and 77 (84 %) of them provided responses on all
acceptability-related questions, thus data, of this subgroup
were considered for the current analysis. The difference
between responders and non-responders was not statisti-
cally significant in terms of age, disease duration, DAS28,
EQ-5D and HAQ-DI scores. Patients’ age was mean 50.3
(SD 12.5) and disease duration was 9.1 (SD 7.7). There
were more females (n = 66, 86 %) than males in the
sample and 65 (84 %) patients were living alone. Disease
activity (DAS28), EQ-5D, EQ VAS and HAQ-DI scores
were 6.00 (SD 0.85), 0.35 (SD 0.36), 46.2 (SD 21.1) and
1.48 (SD 0.66), respectively. Highest educational level was
primary school, secondary school or university in the case
of 21 (27 %), 38 (49 %), 18 (23 %) patients, respectively.
Twenty-two patients (29 %) were working full or part-
time, 14 (18 %) were retired, 33 (43 %) were disability
pensioners, 2 (3 %) patients were students, 3 (4 %)
housewives and 1 (1 %) patient was unemployed (response
was missing in 2 (3 %) cases).
Acceptability of health problems as indicated
on the EQ-5D descriptive system
Results are presented in Table 1. The great majority of RA
patients considered severe health problems as never
acceptable. The ‘Usual activities’ domain is an exception
as 50.6 % of the patients found acceptable if someone at
age 80 or over is unable to carry out housework, family or
leisure activities. Ages 30 or 40 years were marked only by
very few patients. The majority indicated that having some
health problems is acceptable from age 70 (their mean age
was 48.6, SD 12.5 years). However, ages 50 and 60 were
marked also by many patients as acceptable to have some
health problems, especially in the ‘Mobility’, ‘Usual
activities’ and ‘Pain/discomfort’ domains. (Table 1)
Seemingly a significant rate of RA patients found accept-
able to have certain health decline as early as 50 and
60 years of age.
Considering only those patients who did not indicate
‘never’, the majority of the respondents was younger than
the age they pointed as acceptable to have some or severe
problems (77–92 and 88–96 %, respectively, across the
EQ-5D domains).
Comparison with the results of a Dutch population
survey [5] revealed that the highest response rates appeared
at the same age categories in both studies with only two
Table 1 Acceptability of less
than perfect health states (EQ-
5D) beyond a specific age in
percentage of respondents
(N = 77)
Highest response rate is
presented in bold numbers for
each item
Health domains of
the EQ-5D
descriptive system
Level of
problem
Health problems are acceptable from age … and onward (%)
30 years 40 years 50 years 60 years 70 years 80 years Never
Mobility Some
problems
0 3.9 13.0 26.0 32.5 18.2 6.5
Confined
to bed
0 0 0 1.3 7.8 26.0 64.9
Self-care Some
problems
0 0 3.9 19.5 41.6 28.6 6.5
Unable 0 0 0 1.3 2.6 39.0 57.1
Usual activities Some
problems
0 0 7.8 31.2 32.5 22.1 6.5
Unable 0 0 1.3 0 3.9 50.6 44.2
Pain/discomfort Moderate 1.3 1.3 23.4 27.3 33.8 9.1 3.9
Extreme 0 0 2.6 2.6 10.4 28.6 55.8
Anxiety/
depression
Moderate 1.3 2.6 16.9 11.7 27.3 20.8 19.5
Extreme 0 0- 1.3 5.2 7.8 16.9 68.8
S76 M. Pe´ntek et al.
123
exceptions: some problems in self-care were accepted from
age 80 and being moderately anxious/depressed as ‘never’
by the Dutch population sample (the majority of the
Hungarian RA patients indicated age 70 for both, see
Table 1). However, the distribution of responses was dif-
ferent. For instance, altogether 39 % of the RA patients
indicated ages 50 or 60 as acceptable to have some prob-
lems in mobility whilst this rate was only 21 % in the
Dutch public. Similarly, many more RA patients accepted
having moderate pain/discomfort and anxiety/depression
from ages 50 or 60 (51 vs. 26 % and 29 vs. 9 %, respec-
tively). Considering only those respondents who did not
indicate ‘never’, we found that severe health problems
were considered acceptable from somewhat older ages by
the Hungarian RA patients than by Dutch public in all the
five domains of the EQ-5D (Fig. 1).
Comparison of acceptable health states to population
norms by the EQ-5D
In Fig. 2, we present the average EQ-5D scores of RA
patients and the general population in Hungary by age-
groups [12]. Health states (expressed in EQ-5D scores) that
RA patients considered acceptable for ages 30, 40, 50, 60,
70 and 80, respectively, are provided also on this diagram.
RA patients considered better health states acceptable for
ages 30, 40 and 50, than the general population actually has
in age-groups between 25 and 54 years. The two curves
meet at age 60, and an opposite situation is observed for
older ages: RA patients accepted worse health states for
ages 70 and 80 than the general population’s actual scores
are at 65–84 years (Fig. 2). It is noteworthy that RA
patients’ mean health state scores were lower in all age
groups than the level they considered in average acceptable
for the respective ages.
Acceptability of functional problems as indicated
on HAQ-DI
Results are presented in Table 2. Similarly to the findings
with EQ-5D, the worst states (‘unable to do’) were con-
sidered as never acceptable by the majority in each of the
eight areas of functioning. The level of ‘some difficulty’
was acceptable from age 70 in general, and ‘much diffi-
culty’ from age 80. The only exception was the ‘some
difficulty’ in ‘Activities’ (equally 33.8 % for ages 60 and
70). No difficulties in functioning were acceptable for age
30 and only few patients indicated the age 40, either. The
lowest mean age for acceptability appeared in ‘Reach’ and
‘Activities’ domains.
In Fig. 3, patients’ actual mean HAQ-DI scores are
presented by age groups as well as the average HAQ-DI
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Fig. 1 Average age at which health problems are considered
acceptable, as indicated by RA patients who did not indicate ‘never’:
comparison with a population survey from the Netherlands [5]
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Fig. 2 Health status (EQ-5D) of the general population [12] and RA
patients’ scores in comparison with the health deterioration that RA
patients consider acceptable at certain ages. *Average scores are
presented by age groups 25–34, 35–44, 45–54, 55–64, 65–74 and
75–84 years. The number of RA patients in age-groups 18–24 and
75–84 were not sufficient for the analysis. Deducted score calculated
for each age based on the individual responses given to statements of
the EQ-5D
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scores that patients found acceptable from ages 30, 40, 50,
60 70 and 80. A gradual and rather steep worsening of
functional capabilities with ageing was accepted in average
from 60 years and onward (Fig. 3). Note that acceptable
functional states were better than the RA patients’ age-
matched actual average HAQ-DI scores. This is in line with
our findings with EQ-5D as presented above.
Discussion
We have surveyed the acceptability of health problems
among RA patients at the initiation of first biological
treatment. The most severe health states (e.g., being con-
fined to bed, not being able to perform everyday activities
like eating, dressing and grooming or washing themselves)
Table 2 Acceptability of less than perfect functional status (HAQ-DI descriptives) beyond a specific age in percentage of respondents (N = 77)
Health domains of the
HAQ-DI
Level of
problem
Functional problems are acceptable from age … and onward (%) Acceptable from agea,
mean (SD)
30 years 40 years 50 years 60 years 70 years 80 years Never
Dressing and grooming With some
difficulty
0 0 9.1 32.5 37.7 16.9 3.9 66.5 (8.8)
With much
difficulty
0 0 0 5.2 24.7 54.5 15.6 75.8 (6.1)
Unable to do 0 0 0 1.3 3.9 27.3 67.5 78.0 (5.0)
Arising With some
difficulty
0 1.3 13.0 29.9 32.5 18.2 5.2 65.6 (10.0)
With much
difficulty
0 0 1.3 5.2 27.3 44.2 22.1 74.7 (7.0)
Unable to do 0 0 0 1.3 3.9 31.2 63.6 78.2 (4.8)
Eating With some
difficulty
0 2.6 2.6 27.3 37.7 23.4 6.5 68.2 (9.4)
With much
difficulty
0 0 1.3 2.6 20.8 50.6 24.7 76.0 (6.5)
Unable to do 0 0 0 1.3 2.6 29.9 66.2 78.5 (4.6)
Walking With some
difficulty
0 9.1 24.7 37.7 22.1 6.5 67.8 (9.2)
With much
difficulty
0 0 0 7.8 19.5 50.6 22.1 75.5 (6.7)
Unable to do 0 0 0 0 3.9 27.3 68.8 78.8 (3.4)
Hygiene With some
difficulty
0 0 7.8 22.1 48.1 16.9 5.2 67.8 (8.4)
With much
difficulty
0 0 0 6.5 14.3 61.0 18.2 76.7 (6.2)
Unable to do 0 0 0 0.0 6.5 31.2 62.3 78.3 (3.8)
Reach With some
difficulty
0 2.6 6.5 37.7 39.0 10.4 3.9 65.0 (8.8)
With much
difficulty
0 0 1.3 9.1 31.2 46.8 11.7 74.0 (7.4)
Unable to do 0 0 0 2.6 7.8 35.1 54.5 77.1 (5.7)
Grip With some
difficulty
0 3.9 5.2 28.6 36.4 20.8 5.2 66.8 (10.1)
With much
difficulty
0 0 2.6 5.2 27.3 46.8 18.2 74.4 (7.6)
Unable to do 0 0 1.3 1.3 5.2 35.1 57.1 77.3 (6.7)
Activities With some
difficulty
0 2.6 9.1 33.8 33.8 15.6 5.2 65.3 (9.7)
With much
difficulty
0 1.3 1.3 7.8 33.8 41.6 14.3 73.2 (8.3)
Unable to do 0 0 0 3.9 5.2 39.0 51.9 77.3 (6.1)
Highest response rate is presented in bold numbers for each item
a Average age at which these problems in functioning are considered acceptable, as indicated by RA patients who did not indicate ‘never’
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were considered as never acceptable by the great majority
of RA patients. Buitinga et al. [18, 19] came to similar
conclusions as the scenario of being dependent on others
was the most often considered as the worst to experience
by RA patients. Our results, nevertheless, indicate that
moderate health and functional problems are acceptable
from age 70 by the majority, but also a significant rate of
patients indicated ages 50 and 60 as acceptability thresh-
olds. In contrast, RA patients seem to consider ages 30 and
40 as too young to have any health problems or functional
disability (Tables 1, 2). After that, the curve of accept-
ability threshold is almost exponential (Figs. 2, 3).
Some variability can be observed across health areas.
RA patients seem to be more tolerant to moderate problems
presented in the ‘Usual activities’ than in the other four
domains of EQ-5D (Table 1), and similarly, in the
‘Activities’ among the eight domains of HAQ-DI
(Table 2). Overall, rates differ across health domains
indicating that acceptability of health problems varies by
health dimensions. Sanderson et al. [20] explored RA
patients and they confirmed also that patients do prioritize
across specific outcomes.
Interesting findings rise if we put the RA acceptability
results in the context of the health state of the general
population. Comparison by age-groups revealed that RA
patients presented higher criteria for acceptable health
states than the general public actually has at age of 50 and
below (Fig. 2). In contrast, patients accepted much worse
states from age 70 and beyond than the general population
in fact has. Our sample was too small to analyse the
explanatory variables of this reverse shaped gap. The
median age of the sample (52 years) was rather close
although still lower than the age (60 years) where the
population norm and RA patients’ acceptability levels
crossed each other (Fig. 2). Hence, we assume that
patients’ current age might be an important explanatory
factor for acceptability estimates. This hypothesis seems to
be strengthened by the fact that the majority of the
respondents was younger than the age they considered
acceptable to have moderate or severe health problems
(considering only those respondents who did not indicate
‘never’). However, other influencing factors (e.g., sample
selection, gender rate, patients’ age at the onset of the
disease, disease duration or patients’ subjective self-
expectations regarding future health) might have signifi-
cant impact as well. Further studies are needed to provide
firm evidence.
Comparison with findings of a similar survey among the
general population in the Netherlands highlighted many
similarities and some differences [5]. Both studies indi-
cated that worse health states are less acceptable than the
more moderate ones and the acceptability of health prob-
lems is age related. However, a notably higher rate of RA
patients than their Dutch counterparts indicated ages 50 or
60 as acceptable for having some problems in walking
about, having moderate pain or discomfort and being
moderately anxious or depressed. Considering only those
respondents who did not indicate ‘never’, RA patients
marked slightly higher ages as acceptable for severe health
problems than the Dutch public in all the five domains of
EQ-5D (Fig. 1). The discrepancy between acceptability
levels and actual population norms (Fig. 2) was detected
also in the Dutch study but its pattern was different. There
the two curves started from the same point at age 30 and a
broadening gap was observed with the increase of age [5].
It is worth pointing out, however, that the mean age of the
Dutch sample was 30 years and the acceptability of health
problems was not surveyed under this age. Thus, we do not
know whether they would present better than realistic
states as acceptable for younger people. Nonetheless,
comparing Hungarian RA patients with the general popu-
lation from the Netherlands is obviously only a best
available scenario with broad limitations. The life-expec-
tancy at birth in the Netherlands is about seven years
higher than in Hungary and this statistically expected
longer living might influence people’s concerns about
acceptability of health problems in older ages. Differences
in the economic levels, health, social care and reimburse-
ment systems between countries might also shape how
people relate to health, health care and disability problems
(e.g., availability and affordability of costly therapies,
home care, nursing homes, special aids, etc.) [21–23]. We
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Fig. 3 Functional status of RA patients by HAQ-DI and functional
disability they consider to be acceptable at certain ages. *Average
scores are presented by age groups 25–34, 35–44, 45–54, 55–64 and
65–74 years. The number of patients in age-groups 18–24 and 75–84
were not sufficient for the analysis. Deducted score calculated for
each age based on the individual responses given to statements of the
HAQ-DI
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cannot exclude the impact of cultural differences, either.
Some disparities between the two samples (e.g., age, gen-
der rate, health state) are originated presumably from the
nature of the disease. These might also per se have impact
on the findings. Therefore, further controlled studies within
one country or jurisdiction are squarely needed to draw
more forceful conclusions.
Including HAQ-DI, our survey provided additional
information regarding the association between age-related
acceptability and the severity of health problems. HAQ-DI
has 4-level responses whilst EQ-5D has only a 3-level
scale. RA patients made a distinction between age 70 and
80 on HAQ-DI as the highest acceptance rates for the level
‘some difficulty’ appeared for age 70, and for the level
‘with much difficulty’ for age 80. In contrast, age 80 was
indicated only by a minority on EQ-5D, and the highest
proportions appeared mainly for age 70 and in the ‘never’
category (Tables 1, 2). Applying the EQ-5D-5L version
with a 5-level response scale could refine our results.
Nonetheless, findings with HAQ-DI suggest that patients
do indeed care about age when they are thinking about life
over age 70. It would be interesting to expand the survey
for age 90 and beyond, especially in populations with high
life-expectancy.
Direct comparison of Hungarian population norms and
patients’ acceptability results on HAQ-DI is not suitable
due to the disease-specific character of this questionnaire.
Nevertheless, some interesting studies deserve mention-
ing. Krishnan et al. [24] assessed the functional status of
a random sample of adults (n = 1,530) with a HAQ-DI
questionnaire in the Central Finland District. According
to their findings, functional disability increased expo-
nentially with age for both genders. For instance, in the
case of females, the mean HAQ-DI score was \0.1 under
age 50, it increased from 0.16 to 0.77 between age-
groups 50–54 and 70–79 of age, and was a mean of 1.49
in the age-group of C80. Sokka et al. [25] highlighted
that most people over age 50 in the general population
do not meet the American College of Rheumatology
(ACR) criteria for remission in RA. Having these HAQ-
DI ‘norms’ is a further argument in favour of using
HAQ-DI statements in the assessment of acceptability of
health problems.
Some limitations of our study must be noted. The sample
size was small and not representative, thus, our results
cannot be extrapolated to all RA patients who are initiating
biological therapy. Other subsamples, such as RA patients
in younger age, patients with shorter disease duration or in
remission, patients with irreversible joint deformities or
requiring institutionalisation might have very different
views [26]. We have not explored patients’ previous history
(e.g., whether they have had experienced the worst health
states), this is another important point to consider. We did
not include patients’ co-morbidities either (e.g., cardiovas-
cular diseases, fractures or cognitive functions) [27],
although these might also influence the acceptance of health
problems in RA. Further studies involving larger and rep-
resentative samples are encouraged to reveal the explana-
tory factors. Another limitation is the lack of validated
instruments to assess acceptability. In this study we used
statements of EQ-5D and HAQ-DI and patients evaluated
them one by one. It is very likely that patients would have
given different results if they had to evaluate combinations
of the statements. Nevertheless, this way of surveying (with
EQ-5D) was used successfully in a previous research [5],
and we have had good experiences as well in terms of
feasibility. Alongside the cons, there are pros that justify
our approach. The natural course of the disease in RA can
be described by HAQ-DI and minimally important differ-
ence estimates have been established for both question-
naires [28]. HAQ-DI makes part of a composite index called
ACR criteria, which is a core instrument in clinical trials to
assess clinical improvement [29]. The HAQ-DI score is
often collected in RA registries as well [30]. EQ-5D is the
most frequently used tool to measure utility in health eco-
nomic evaluations in RA [31]. Thus, assessing acceptability
of deterioration of general health and functioning in RA
with questionnaires based on EQ-5D and HAQ-DI can open
the door for comparisons between patients’ acceptability
concerns and long term cohorts, as well as randomized
controlled trial data. Applying the EQ-5D creates the pos-
sibility for comparisons across different chronic diseases,
another interesting area for investigation. Being aware of
the limitations of our study is obviously crucial in the
interpretation of the results. Hence, we consider our survey
more as a pilot with explorative purposes that confirmed the
importance of the topic and revealed promising fields for
further research. It is important to mention, and cannot be
overemphasized, that our results are not to justify inade-
quate care or unreasonable patient selection. Contrarily, we
believe that the better understanding of age related health
concerns can help to bridge the information asymmetry
between RA patients and health professionals, and as a
result, improve RA patients’ health.
In conclusion, acceptability of less than perfect health
states exists and is an issue for further discussion in RA.
Expanding our knowledge on patients’ beliefs regarding
age related health might improve the communication
between patients and health professionals. Owing to the
impact RA patients’ reference points for health might have
on their needs and compliance, the topic deserves meth-
odological improvement and further investigation.
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